# Pfizer vs Vertex Pharmaceuticals: stocks compared

URL: https://funkfolio.com/compare/pfe-vs-vrtx

> Pfizer ($162.3B, P/E 40.7) and Vertex Pharmaceuticals ($135.4B, P/E 34.4) compared: size, valuation, margins, debt, cash and price change.

---

## Pfizer vs Vertex Pharmaceuticals

Pfizer (PFE), health care, and Vertex Pharmaceuticals (VRTX), health care, side by side on market value, valuation, margins, balance sheet and price change. Higher and lower are marked; neither is called better.

Pfizer is worth $162.3B on the stock market and Vertex Pharmaceuticals $135.4B: Pfizer is valued at 20% more. Pfizer trades at 40.7 times earnings and Vertex Pharmaceuticals at 34.4. Over the past year Pfizer's share price has moved +13.4% and Vertex Pharmaceuticals's +23.5%.

### Key facts

- **Pfizer market value:** $162.3B
- **Vertex Pharmaceuticals market value:** $135.4B
- **Pfizer P/E:** 40.7
- **Vertex Pharmaceuticals P/E:** 34.4
- **Pfizer revenue:** $62.6B FY to 2025-12-31
- **Vertex Pharmaceuticals revenue:** $12B FY to 2025-12-31
- **Superinvestors holding both:** 0

Market values as of 18 Nov 2026, 02:56 UTC.

Pfizer vs Vertex Pharmaceuticals: every measure side by side

| Measure | Pfizer | Vertex Pharmaceuticals |
| --- | --- | --- |
| Sector | Health Care | Health Care |
| Country | United States | United States |
| Fiscal year ends | 2025-12-31 | 2025-12-31 |
| Size |  |  |
| Market cap | $162.3B higher | $135.4B lower |
| Revenue | $62.6B higher | $12B lower |
| Earnings | $7.8B higher | $4B lower |
| Employees | 75,000 higher | 6,400 lower |
| Total assets | $208.2B higher | $25.6B lower |
| Valuation |  |  |
| P/E | 40.7 higher | 34.4 lower |
| P/S | 2.6 lower | 11.3 higher |
| P/B | 1.8 lower | 6.5 higher |
| Dividend yield | 7.45% higher | 0.00% lower |
| Profitability |  |  |
| Operating margin | — | 34.8% |
| Balance sheet |  |  |
| Net assets | $86.5B higher | $18.7B lower |
| Total liabilities | $121.4B higher | $7B lower |
| Total debt | $64.8B | — |
| Cash on hand | $1.1B lower | $5.1B higher |
| Price change |  |  |
| Today | -1.35% lower | -0.67% higher |
| 1 year | +13.4% lower | +23.5% higher |

Market value, P/E, P/B, dividend yield and price changes are from live quotes (Yahoo Finance; prices may be delayed 15 minutes or more). Revenue, earnings, operating margin and the balance-sheet figures are from each company's latest annual report filed with the SEC (collected 2026-11-12); a company that reports in another currency is converted to US dollars at the exchange rate of that day. P/S sets today's market value against the latest fiscal year's revenue. “Higher” and “lower” compare the two numbers only; a higher P/E or more debt is not better. Dividend yield and P/B are shown only for companies based in the US. A dash means no figure is on file.

### Share price over one year

Each company's share price rebased to 100 on Nov 17, 2025, so the two lines start together. Price only: dividends are not included. Last: Pfizer 113.5, Vertex Pharmaceuticals 123.1.

- Pfizer (PFE)
- Vertex Pharmaceuticals (VRTX)

Pfizer and Vertex Pharmaceuticals share prices over one year, rebased to 100: Pfizer ends at 113.5, Vertex Pharmaceuticals at 123.1.

**The chart as a table**

Month-end share prices rebased to 100

| Month end | PFE | VRTX |
| --- | --- | --- |
| Nov 28, 2025 | 102.6 | 99.9 |
| Dec 31, 2025 | 99.3 | 104.5 |
| Jan 30, 2026 | 105.4 | 108.3 |
| Feb 27, 2026 | 110.2 | 114.5 |
| Mar 31, 2026 | 112.0 | 102.9 |
| Apr 30, 2026 | 106.5 | 98.5 |
| May 29, 2026 | 104.4 | 103.1 |
| Jun 30, 2026 | 96.0 | 114.4 |
| Jul 31, 2026 | 99.7 | 109.9 |
| Aug 31, 2026 | 113.5 | 125.5 |
| Sep 30, 2026 | 113.7 | 120.5 |
| Oct 30, 2026 | 121.7 | 128.8 |
| Nov 17, 2026 | 113.5 | 123.1 |

### Which superinvestors hold them

From each tracked investor's latest 13F filing. A 13F lists long positions in US-listed shares at a quarter end, filed up to 45 days later.

#### Both (0)

None of the tracked investors.

#### Pfizer only (11)

- [Thomas Kahn](https://funkfolio.com/gurus/thomas-kahn) 1.9%
- [Mark Boyar](https://funkfolio.com/gurus/mark-boyar) 1.6%
- [Prem Watsa](https://funkfolio.com/gurus/prem-watsa) 1.5%
- [Charles Brandes (founder)](https://funkfolio.com/gurus/charles-brandes) 1.5%
- [Josef Lakonishok](https://funkfolio.com/gurus/josef-lakonishok) 1.0%
- [Ken Fisher](https://funkfolio.com/gurus/ken-fisher) 0.9%
- [Richard Pzena](https://funkfolio.com/gurus/richard-pzena) 0.5%
- [Bruce Berkowitz](https://funkfolio.com/gurus/bruce-berkowitz) 0.4%
- [Jeremy Grantham (co-founder)](https://funkfolio.com/gurus/jeremy-grantham) 0.1%
- [Murray Stahl](https://funkfolio.com/gurus/murray-stahl) &lt;0.1%
- [Mairs & Power team](https://funkfolio.com/gurus/mairs-and-power) &lt;0.1%

#### Vertex Pharmaceuticals only (5)

- [Tweedy, Browne team](https://funkfolio.com/gurus/tweedy-browne) 1.1%
- [Jim Simons (1938–2024)](https://funkfolio.com/gurus/jim-simons) 0.3%
- [Israel Englander](https://funkfolio.com/gurus/israel-englander) 0.2%
- [Ken Griffin](https://funkfolio.com/gurus/ken-griffin) 0.1%
- [Baillie Gifford team](https://funkfolio.com/gurus/baillie-gifford) 0.1%

Percentages are each holding's share of that investor's reported portfolio. [Who owns PFE](https://funkfolio.com/stock/PFE/superinvestors) · [Who owns VRTX](https://funkfolio.com/stock/VRTX/superinvestors)

### More on Pfizer

- [Pfizer (PFE) stock page](https://funkfolio.com/stock/PFE)
- [Pfizer market cap](https://funkfolio.com/stock/PFE/market-cap)
- [Pfizer revenue](https://funkfolio.com/stock/PFE/revenue)
- [Pfizer P/E ratio](https://funkfolio.com/stock/PFE/pe-ratio)
- [Pfizer operating margin](https://funkfolio.com/stock/PFE/operating-margin)
- [Pfizer total debt](https://funkfolio.com/stock/PFE/total-debt)
- [Largest health care companies](https://funkfolio.com/companies/sector/health-care)

### More on Vertex Pharmaceuticals

- [Vertex Pharmaceuticals (VRTX) stock page](https://funkfolio.com/stock/VRTX)
- [Vertex Pharmaceuticals market cap](https://funkfolio.com/stock/VRTX/market-cap)
- [Vertex Pharmaceuticals revenue](https://funkfolio.com/stock/VRTX/revenue)
- [Vertex Pharmaceuticals P/E ratio](https://funkfolio.com/stock/VRTX/pe-ratio)
- [Vertex Pharmaceuticals operating margin](https://funkfolio.com/stock/VRTX/operating-margin)
- [Vertex Pharmaceuticals total debt](https://funkfolio.com/stock/VRTX/total-debt)
- [Largest health care companies](https://funkfolio.com/companies/sector/health-care)

### Further comparisons

#### Pfizer against its closest peers

- [Pfizer vs Danaher](https://funkfolio.com/compare/dhr-vs-pfe)
- [Pfizer vs Intuitive Surgical](https://funkfolio.com/compare/isrg-vs-pfe)
- [Pfizer vs Novo Nordisk](https://funkfolio.com/compare/nvo-vs-pfe)
- [Pfizer vs Abbott Laboratories](https://funkfolio.com/compare/abt-vs-pfe)

#### Vertex Pharmaceuticals against its closest peers

- [Vertex Pharmaceuticals vs Medtronic](https://funkfolio.com/compare/mdt-vs-vrtx)
- [Vertex Pharmaceuticals vs Bristol-Myers Squibb](https://funkfolio.com/compare/bmy-vs-vrtx)
- [Vertex Pharmaceuticals vs Intuitive Surgical](https://funkfolio.com/compare/isrg-vs-vrtx)
- [Vertex Pharmaceuticals vs Danaher](https://funkfolio.com/compare/dhr-vs-vrtx)

### Learn

- [What market capitalization is and is not](https://funkfolio.com/learn/markets/market-capitalization)
- [P/E ratio explained](https://funkfolio.com/learn/stocks/pe-ratio)
- [Market cap vs enterprise value](https://funkfolio.com/learn/markets/market-cap-vs-enterprise-value)

### Questions and answers

**Which is bigger, Pfizer or Vertex Pharmaceuticals?**

By market value, Pfizer is the larger: $162.3B against $135.4B for Vertex Pharmaceuticals. By revenue in its latest fiscal year, Pfizer is the larger: $62.6B against $12B for Vertex Pharmaceuticals.

**Which has the higher P/E ratio?**

Pfizer: 40.7, against 34.4 for Vertex Pharmaceuticals. A higher P/E means the market pays more for each dollar of the last twelve months' earnings; on its own it does not say which is the better value.

**Which has the higher dividend yield?**

Pfizer: 7.45%, against 0.00% for Vertex Pharmaceuticals. Dividend yield is the last twelve months' dividends as a share of today's share price.

**Which superinvestors own both Pfizer and Vertex Pharmaceuticals?**

None of the tracked superinvestors holds both in their latest 13F filing. 11 hold Pfizer and 5 hold Vertex Pharmaceuticals.

### Cite this page

Funkfolio, “Pfizer vs Vertex Pharmaceuticals”, data as of 18 November 2026. https://funkfolio.com/compare/pfe-vs-vrtx

Underlying data: Yahoo Finance quotes; SEC annual reports collected 2026-11-12; 13F filings.
